Johnson & Johnson Executives Say Administration Of The Company’s Covid-19 Vaccine Will Resume Soon

Regulators in the EU and US meet this week to determine whether to resume administering the vaccine after reports of an extremely rare blood clotting side effect.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive